Deal facts
- Buyer
- Coeptis Therapeutics Holdings, Inc.
- Target
- Z Squared Inc.
- Deal value
- Not disclosed
- Announced
- 25 April 2025
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- shares
Sources
Deal timeline
1 update- CompletedClosed
Coeptis Therapeutics Holdings, Inc. completes acquisition of Z Squared Inc.
Item 2.01 Completion of Acquisition or Disposition of Assets Item 5.01 Changes in Control of the Registrant Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01 Financial Statements and Exhibits ii TA
Source
For business owners
What would selling your own business involve?
Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.
Guides are free to read. Free tools require email access; indicative results are not professional advice.
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
MaxCyte, Inc. to acquire Akron BioProducts LLC
MaxCyte, Inc., the Nasdaq-listed cell-engineering company, has agreed to acquire Akron BioProducts LLC from affiliates of Arcline Investment Management. The Securities P…
- Buyer
- MaxCyte, Inc.
- Target
- Akron BioProducts LLC
- Deal value
- USD 151,800,000
- Deal type
- strategic acquisition
New Horizon Pharma B.V. to acquire Phatebo GmbH
ZeroStack Corp. disclosed in a Form 8-K, accepted by the SEC on 9 November 2026, that on 3 November 2026 it signed a Share Purchase and Transfer Agreement with New Horiz…
- Buyer
- New Horizon Pharma B.V.
- Target
- Phatebo GmbH
- Deal value
- EUR 2,150,000
- Deal type
- strategic acquisition
Brains Therapeutics Corp. to acquire Brains Bioceutical Corp.
Armada Acquisition Corp. III, a Cayman Islands SPAC, signed a Business Combination Agreement on October 31, 2026 with Armada Sponsor III, LLC, Brains Bioceutical Corp. a…
- Buyer
- Brains Therapeutics Corp.
- Target
- Brains Bioceutical Corp.
- Deal value
- USD 750,000,000
- Deal type
- strategic acquisition
BioAdaptives, Inc. to acquire Xycota Biosciences LLC
BioAdaptives, Inc. entered into a definitive Membership Interest Purchase Agreement on October 29, 2026 to acquire 100% of the issued and outstanding membership interest…
- Buyer
- BioAdaptives, Inc.
- Target
- Xycota Biosciences LLC
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Coeptis Therapeutics Holdings, Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive